Addex Therapeutics Ltd
SWXAddex Therapeutics enters the week after its full-year 2025 results with an unusual combination: a stock trading below five Swiss centimes, a borrow market that remains extraordinarily expensive, and a pipeline that just delivered a positive preclinical readout. The most striking feature of the ADXN setup right now is the cost to borrow. At 197% APR, it has held above 170% for the…
Snapshot as of 8 May 2026
Addex Therapeutics enters the week after its full-year 2025 results with an unusual combination: a stock trading below five Swiss centimes, a borrow market that remains extraordinarily expensive, and a pipeline that…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ADXN — free to start on ORTEX.
Sign up for free →Open ADXN on ORTEX